期刊文献+

心房颤动患者抗凝治疗的护理与观察 被引量:7

The nursing and observation of the atrial fibrillation patients with anticoagulation therapy
在线阅读 下载PDF
导出
摘要 目的观察房颤患者应用华法林抗凝治疗的临床过程,探讨其护理要点。方法回顾356例房颤患者住院期间服用华法林抗凝治疗的观察与护理经过。结果 356例患者住院期间均能够按时按量服用华法林,其中228例反映刷牙时牙龈易出血和(或)皮肤采血部位止血时间较前延长,无1例患者发生血尿、便血、呕血、脑出血、脑栓塞等并发症。结论健康教育是提高房颤患者口服华法林抗凝治疗依从性、保障患者安全的重要手段,教育的重点在于饮食及服药指导,定期监测国际标准化比值及出血的自我观察。 Objective To discuss the nursing points for anticoagulant therapy through observing the clinical course of atrial fibrillation patients who applicated with warfarin.Methods Review the observation and nursing process of 356 atrial fibrillation patients who took warfarin.Results 356 patients were able to take warfarin with orders,228 patients demonstrated bleeding gums when brushing teeth and/or the longer hemostasia time of the inserition point,none of them had the complication of hematuria,hematochezia,hematemesis,cerebral hemorrhage,or cerebral embolism.Conclusions Health education is an important means to improve the adherence and ensure patients safety in oral warfarin anticoagulant treatment for atrial fibrillation patients.The focus of the education is on diet,medication guidance,monitoring INR on time and self-observation of haemorrhage.
出处 《实用临床医药杂志》 CAS 2011年第2期11-13,共3页 Journal of Clinical Medicine in Practice
关键词 心房颤动 抗凝 护理 atrial fibrillation anticoagulant therapy nursing
  • 相关文献

参考文献7

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1403
  • 2胡大一,杨新春.心血管疾病治疗中“难点”问题[J].中国实用内科杂志,2000,20(5):259-261. 被引量:29
  • 3Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)[J].J Am Coll Cardiol,2006,48:149.
  • 4许俊堂.口服华法林INR的波动及其调节[J].中国医刊,2006,41(8):46-48. 被引量:10
  • 5FangMC,Go AS,Hylek EM,et al.Age and the risk ofwarfarin-associated hemorrhage:the anticoagulation and risk factors in atrial fibrillation study[J].J Am Geriatr Soc,2006,54::1231,.
  • 6Fuster V,Ryden LE,Cannom DS,et al.ACC/ AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Circulation,2006,114:257.
  • 7连耀植,张云,杨敏,张钰,许端敏,陈畅,闫纯英,张汉灵.华法令在心房颤动患者的应用研究[J].中国实用内科杂志,2004,24(5):285-286. 被引量:9

二级参考文献8

  • 1陈修 陈维洲.心血管药理学(第2版)[M].北京:人民卫生出版社,1997.229.
  • 2Hirsh J, Fuster V,Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. JAm Coll Cardiol,2003,41 (9):1633-1652
  • 3The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillationand recent cerebral ischemia. N Engl J Med,1995,333(1) :5-10
  • 4Yamaguchi T. Optimal intensity of warfarin therapy for secondaryprevention of stroke in patients with nonvalvular atrial fibrillation. Amulticenter, prospective, randomized trial. Stroke, 2000,31 (4): 817 -821
  • 5孙瑞龙,李庚山.加强心房颤动的研究[J].中国心脏起搏与心电生理杂志,1997,11(3):113-114. 被引量:30
  • 6许蓬娟,李悠悠,孙梓翔.酵素在生物作用中的研究进展[J].食品与发酵科技,2017,53(1):83-85. 被引量:10
  • 7白浩,文佳嘉,费爽雯,袁水林,李欣.酵素的功能与综合应用研究进展[J].食品工业,2017,38(6):270-272. 被引量:40
  • 8胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:362

共引文献1446

同被引文献56

  • 1颜红兵,郑斌.心房颤动合并冠心病的抗栓治疗[J].岭南心血管病杂志,2009,15(5):340-344. 被引量:3
  • 2邬丽萍,李朝伟,王燕.冠状动脉支架术后患者应用抗凝药物治疗的观察与护理[J].当代护士(下旬刊),2010,17(3):17-18. 被引量:3
  • 3匡洪梅,王永梅.对行PCI术后抗凝抗血小板治疗致消化道出血患者的护理[J].求医问药(下半月),2013(2):157-158. 被引量:3
  • 4朱大乔,毛红娟,何丹丹,李雪玉,王玚.高血压患者自我监测血压对药物治疗依从性的影响[J].中华护理杂志,2004,39(8):581-583. 被引量:75
  • 5张振香.射频消融术后心房颤动患者的危险因素与护理[J].护理学杂志,2007,22(7):27-29. 被引量:3
  • 6Karmel W B, Abbott R D, Savage D D, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study [J]. N Engl J Med, 1982, 306(17): 1018.
  • 7Carom A J, Kirchhof P, Lip G Y, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2010, 31(19) : 2369.
  • 8Furberg C D, Psaty B M, Manolio T A, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) [J]. Am J Cardiol, 1994, 74(3) : 236.
  • 9Fuster V, Ryden L E, Cannom D S, et al. 2011 ACCF/ AHA/HRS focused updates incorporated into the ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines [ J ]. Circulation, 2011, 123 (10): 269.
  • 10Calkins H, Brugada J, Packer D L, et al. HRS/EHRA/E- CAS expert Consensus Statement on catheter and surgical ab- lation of atrial fibrillation: recommendations for personnel, policy, procedures and follow- up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgicalablation of atrial fibrillation [ J ]. Heart Rhythm, 2007, 4 (6) : 816.

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部